Thu, February 22, 2018
Wed, February 21, 2018
Tue, February 20, 2018
Fri, February 16, 2018
Thu, February 15, 2018
Wed, February 14, 2018
Tue, February 13, 2018
Mon, February 12, 2018
Fri, February 9, 2018
Thu, February 8, 2018
Wed, February 7, 2018

Liisa Bayko Maintained (VRTX) at Buy with Increased Target to $211 on, Feb 13th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-211-on-feb-13th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Liisa Bayko of JMP Securities, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $200 to $211 on, Feb 13th, 2018.

Liisa has made no other calls on VRTX in the last 4 months.



There are 4 other peers that have a rating on VRTX. Out of the 4 peers that are also analyzing VRTX, 0 agree with Liisa's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Liisa


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Friday, February 2nd, 2018
  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $197 on, Thursday, February 1st, 2018
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $191 on, Thursday, February 1st, 2018
  • Geoff Meacham of "Barclays" Maintained at Buy with Increased Target to $200 on, Thursday, February 1st, 2018